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Measuring Lead Effects
Blood and Bone Together Are Better
Many studies have reported impaired renal function
and kidney disease at high levels of lead exposure, as
estimated mainly through concentrations of serum
creatinine (SCr) and rates of creatinine clearance from
the body. However, lower-level lead exposure has not
been correlated with renal effects as conclusively, per-
haps because blood lead reflects relatively recent expo-
sure, and therefore is not an adequate measure of total
body burden. This month, Shirng-Wern Tsaih of the
Harvard School of Public Health and her colleagues
report that blood lead levels alone may not be enough
to determine whether kidney effects are occurring at
low exposure; lead levels in bone also need to be deter-
mined [EHP 112:1178–1182]. The Tsaih study is
among the first to assess the relationship between low-
level bone and blood lead levels and measures of kid-
ney function in a general population sample. 
In contrast with blood lead, bone lead makes up
more than 95% of the adult body burden. The lead
in more compacted cortical bones, such as the tibia,
is less available for mobilization, because this type of
bone is less prone to turnover than spongier trabecular bones, such
as the patella. Yet, as people age, bone loss often does take place, so
lead that has long been held in bone is released to soft tissue and
can find its way to the kidneys. Thus, bone lead may be a better
marker for studying the chronic toxicity of accumulated exposure
and lead burden.
The Tsaih study examined data from a cohort of middle-aged and
elderly Boston men with no known heavy exposure to lead.
Participants were from the Normative Aging Study, a federal study of
aging begun in 1961. A blood sample for lead analysis had been col-
lected every 3–5 years since July 1988; bone lead measurements began
in August 1991, when a subset of participants were recruited for a
substudy in which bone lead was measured by K X-ray fluorescence. 
Tsaih and colleagues examined data for 448 men who had a base-
line bone lead measurement between 1991 and 1995, and follow-up
measurements of SCr 4–8 years later. They examined blood and bone
lead concentrations and their correlation with kidney function, taking
into account the known nephrotoxic effects of diabetes mellitus and
hypertension, which had been diagnosed in 5.8% and 25.7% of the
men, respectively, at the time of baseline measurement. Bone lead was
measured in the tibia and patella. 
Tibia lead was observed to be associated with increases in SCr lev-
els in follow-up participants with diabetes. The findings suggest that
long-term low-level lead accumulation, estimated by tibia lead, is asso-
ciated with an increased risk of reduced renal function. This is espe-
cially true for diabetics and hypertensives, who already are at risk for
kidney impairment because of their disease. In addition, blood lead
and tibia lead appeared to be associated with elevated SCr levels and
chronic kidney disease among hypertensives. There was no statistical
evidence of patella lead being associated with change in renal func-
tion, suggesting that chronic absorption of lead is a risk factor for
impaired renal function. 
The study, however, has some limitations. Although SCr is widely
used in medicine to measure overall renal function, it provides only a
rough estimate of the kidney’s filtration capacity. For instance,
increases in SCr definitively show impairment only when kidney
function has been reduced by about 50%. Thus, the researchers had
great difficulty in detecting more modest effects of lead. In addition,
the alternative hypothesis that elevated blood or bone lead levels actu-
ally result from impaired kidney function cannot be ruled out.
It has not yet been determined whether lead affects blood pressure
indirectly through changes in kidney function, or via more direct
effects on the circulatory system or neurological blood pressure con-
trol. The researchers also know of no studies to date that analyze the
potential for diabetes to modify the relationship between lead exposure
and renal function. Given that many adults have a history of environ-
mental or occupational lead exposure and the incidence of both type 2
diabetes and hypertension, studies of such interactions, if confirmed,
could be of significant public health value. –Julian Josephson
Risky Trade-offs
Bangladeshi Quest for Safe Water
In an attempt to eliminate epidemic levels of diarrhea and other
infectious diseases associated with the use of surface waters, millions
of shallow tube wells were drilled into the Ganges Delta alluvium in
Bangladesh beginning in the early 1970s. This process reduced the
rates of water-related infectious diseases but created a new public
health dilemma: a surge in diseases such as skin ailments, diabetes
mellitus, and various cancers, all resulting from habitual consump-
tion of groundwater naturally high in arsenic. 
A number of interventions have been proposed to help remedy
the widespread arsenic exposure, but these interventions may only be
bringing the catastrophic water situation in Bangladesh full circle. A
new study by epidemiologists led by Kamalini Lokuge of the
Australian National University suggests that, while these interventions
will eventually result in less disease overall, they may initially cause a
steady and considerable increase in diarrheal disease [EHP
112:1172–1177]. The study indicates that any large-scale transition
away from household tube wells as a source of drinking water, with-
out proper evaluation of the risks, may be premature.
In attempting to quantify the disease burden resulting both from
arsenic exposure and from the potential side effects of widely available
arsenic mitigation interventions, Lokuge and her colleagues used pre-
viously published information to estimate mortality rates and disabili-
ty-adjusted life years (DALYs). Simply put, a DALY is a measure of
the burden of disease; it reflects how much a person’s expectancy of
healthy life is reduced by premature death as well as by disability
caused by disease. 
A step in the right direction. Correlating bone lead measurements (obtained through
K X-ray fluorescence) with blood lead data yields insights into adverse renal effects.Science Selections
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The Australian team used World Health Organization data to esti-
mate the DALYs lost per year to arsenic-related effects including dia-
betes, ischemic heart disease, and a number of cancers. They calculated
that arsenic exposure causes the loss of 174,174 DALYs per year in
Bangladeshis exposed to arsenic concentrations above 50 micrograms
per liter (µg/L), the nation’s cut-off point for safe drinking water. 
Then they calculated the DALYs that would be lost to infectious
disease, provided Bangladeshis adopted certain arsenic mitigation
options currently advocated by the federal Bangladesh Arsenic
Mitigation and Water Supply Project and immediately accessible to
the majority of the Bangladeshi population year-round. These include
surface water supplies, uncontaminated community tube wells, and
low-cost filtration systems. These alternative options carry the poten-
tial for increased water-related infections, compared with household
tube wells. 
Assuming that mitigation efforts were undertaken only in those
areas where the arsenic concentration of drinking water is highest
(100–300 µg/L), the team found that the long-range benefits of
arsenic mitigation in terms of DALYs gained and deaths avoided
would outweigh any initial decline in public health due to water-
related infectious diseases. However, there would initially be a period
of some years (the number of which is still unknown) before any
benefit would accrue, and some additional years until the total bene-
fit outweighed the cost of the water-related infectious disease
increase. The investigators also conclude, moreover, that if the
Bangladeshi people gradually stop using the alternative water sources
and processes (for example, because of the inconvenience of mainte-
nance or complacency as disease drops off), the initial DALY-based
cost of water-related infectious diseases would remain while the long-
range benefits would disappear.
The study demonstrates that implementation of any arsenic-miti-
gating intervention must take into account not only the strategy’s
effectiveness in reducing arsenic exposure but also its safety in terms of
water-related infectious diseases, the likelihood of population-wide
compliance, and different exposure levels within the population. The
investigators contend that such information is vital to developing
appropriate policies toward resolving the drinking water crisis in
Bangladesh. –M. Nathaniel Mead
Spraying on a Summer Night
A Safer Way to Stop West Nile Virus
A population-level study has shown that night-time pesticide spray-
ing in the late summer and early fall, aimed at controlling adult mos-
quitoes that carry West Nile virus, can be done in a way that does
not drive up the number of people seeking emergency care for asth-
ma-related problems [EHP 112:1183–1187]. A team led by Adam
M. Karpati, a physician in the New York City Department of
Health and Mental Hygiene, reports that in studies of the city’s
2000 mosquito spraying season, no correlation could be found
between broad application of sumithrin (a pyrethroid pesticide) and
asthma cases presenting at the city’s 11 public hospital emergency
departments. 
Earlier studies had shown that high exposure to pyrethroid pesti-
cides—often in an occupational setting—can trigger reactions in asth-
ma sufferers ranging from mild symptoms such as sneezing and
scratchy throat to more acute ones such as wheezing, chest tightness,
and even death. But no data have been available showing on a popula-
tion scale how the lower-level exposures that come from public health
spraying of pesticides affect the large number of asthmatics that may
live in a big city. 
The researchers tabulated data for asthma-related emergency room
visits around the dates when a sumithrin-based pesticide was sprayed
in each of 162 residential zip code areas in the city during
July–September 2000. The timing of spraying within each zip code
depended on whether surveillance indicated it was warranted—for
example, if a dead bird were found to be infected with the virus, or if a
human case were identified. A zip code area was rarely sprayed on
consecutive days. The study also incorporated air quality data includ-
ing daily measures of ozone, air particulates, and temperature, which
can all cause fluctuations in the number of people seeking treatment
for asthma-related symptoms. For a control, the team used asthma-
related emergency room visits on days prior to spraying. They also
looked at the number of asthma-related emergency room visits before
and after the spraying season.
The researchers found that the number of asthma-related visits in
the three days before application of the pesticide and the three days
after were nearly identical. Looking more specifically within the emer-
gency department data for asthma flare-ups in children and for aggra-
vation of chronic obstructive pulmonary disease similarly yielded no
correlation between spraying and symptoms. 
The study does not necessarily show that public health
pyrethroid spraying is not a danger to asthmatics. Rather, it could
suggest that the city’s method of application and/or the citizens’
behavior during spraying helped minimize exposure. During 2000,
the first year when New York City exclusively used a pyrethroid pes-
ticide, the city limited its spraying to areas where the virus was
detected in birds, mosquitoes, or humans, with spray trucks usually
beginning their rounds near 10 p.m. and continuing through the
night to 5 a.m. Radio, television, and print media were used to alert
residents 48 hours prior to any spraying and to instruct people to
remain indoors and close their windows during the hours when
spraying would occur. –Victoria McGovern
Big Apple air okay. Mosquito pesticide spraying to prevent West Nile
virus was not associated with an increase in asthma attacks.